论文部分内容阅读
目的:观察并分析脑保护剂与降纤药物在治疗急性脑梗塞上的临床效果。方法:将2013年7月至2014年8月在我院接受治疗的100例急性期脑梗塞患者作为此次研究的对象,按照随机分配的方法将患者分为实验组(n=50)和对照组(n=50),给予对照组患者降纤药物治疗,给予实验组患者脑保护剂与降纤药物联合治疗,观察并对比两组患者的治疗效果。结果:实验组患者的治疗效果优于对照组患者(P<0.05),数据间的差异有统计学意义。结论:在治疗急性期脑梗塞上,应用脑保护剂与降纤药物进行治疗可取得较好的临床效果,值得大力推广应用。
Objective: To observe and analyze the clinical effect of brain protective agents and fibrinolytic drugs in the treatment of acute cerebral infarction. Methods: A total of 100 patients with acute cerebral infarction who were treated in our hospital from July 2013 to August 2014 were enrolled in this study. Patients were randomly divided into experimental group (n = 50) and control group (N = 50). The patients in the control group were treated with antifibrillar drugs. The patients in the experimental group were treated with combination of brain protective agent and antifibrinolytic drugs. The therapeutic effect was observed and compared between the two groups. Results: The treatment effect of the experimental group was better than that of the control group (P <0.05), and the difference was statistically significant. Conclusion: In the treatment of acute cerebral infarction, the application of brain protective agents and antifibrinolytic drugs can achieve better clinical results, which is worth popularizing.